NCT01863550-D1
Dataset Information
Dataset ID: NCT01863550-D1
PubMed ID (PMID):
Publication Title:
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
Description of Dataset:
There are seven different submissions for PMID 32866432 from trial E1A11. This dataset, NCT01863550-D1, contains baseline, treatment, and efficacy data. Dataset NCT01863550-D2 contains treatment dose by cycle. Dataset NCT01863550-D3 contains information related to first dose modification. Dataset NCT01863550-D4 contains toxicity data reported by case report forms. Dataset NCT01863550-D5 contains adverse events submitted via expedited reporting. Dataset NCT01863550-D6 contains secondary primary cancers. Dataset NCT01863550-D7 contains patients reported quality-of-life data.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT01863550 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®